Adomeglivant

CAS No. 1488363-78-5

Adomeglivant( LY-2409021 )

Catalog No. M12058 CAS No. 1488363-78-5

A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 Get Quote
5MG 87 Get Quote
10MG 132 Get Quote
25MG 213 Get Quote
50MG 390 Get Quote
100MG 575 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adomeglivant
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM.
  • Description
    A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM; displays >200-fold selectivity over related receptors; exhibits robust glucose-lowering in response to daily oral administration in an ob/ob mouse model of type 2 diabetes mellitus.Diabetes Phase 2 Discontinued.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Avpires-Cre+ miceDosage:5 mg/kg Administration:Intraperitoneal injection, 30 minutes prior to CNOResult:Completely abolished the hyperglycaemic action of CNO.
  • Synonyms
    LY-2409021
  • Pathway
    GPCR/G Protein
  • Target
    Glucagon Receptor
  • Recptor
    Glucagon Receptor
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    1488363-78-5
  • Formula Weight
    555.6277
  • Molecular Formula
    C32H36F3NO4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 5.3 mg/mL
  • SMILES
    O=C(O)CCNC(C1=CC=C([C@@H](OC2=CC(C)=C(C3=CC=C(C(C)(C)C)C=C3)C(C)=C2)CCC(F)(F)F)C=C1)=O
  • Chemical Name
    β-Alanine, N-[4-[(1S)-1-[[4'-(1,1-dimethylethyl)-2,6-dimethyl[1,1'-biphenyl]-4-yl]oxy]-4,4,4-trifluorobutyl]benzoyl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kelly RP, et al. Diabetes Obes Metab. 2015 Apr;17(4):414-22. 2. Grover S, et al. BMC Bioinformatics. 2014;15 Suppl 16:S13. 3. Kazda CM, et al. Diabetes Obes Metab. 2017 Aug;19(8):1071-1077.
molnova catalog
related products
  • GLP-1 receptor agoni...

    1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist.

  • des-His1-[Glu9]-Gluc...

    Glucagon receptor antagonist (pA2 = 7.2 for inhibition of glucagon-induced adenylyl cyclase activation in rat liver membranes); displays no agonist activity. Enhances glucose-stimulated pancreatic insulin release in vitro. Blocks added glucagon-induced hyperglycemia in normal rabbits without affecting glycogenolysis in vivo. Also blocks endogenous glucagon-induced hyperglycemia in streptozocin diabetic rats.

  • Bay 55-9837

    Selective VPAC2 receptor agonist (EC50 values are 0.4, 100 and >1000 nM for VPAC2, VPAC1 and PAC1, respectively in a cAMP accumulation assay; IC50 values are 60, 8700 and >10000 nM for VPAC2, VPAC1 and PAC1, respectively in a competition binding assay). Stimulates glucose-dependent insulin secretion in isolated human pancreatic islets. Reduces HIV-1 viral replication and shows cooperative effects when given in conjunction with VPAC1 agonists.